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Abstract
Influenza A virus (IAV) polymerase complexes function in the nucleus of infected cells, generating mRNAs that bear 59 caps
and poly(A) tails, and which are exported to the cytoplasm and translated by host machinery. Host antiviral defences include
mechanisms that detect the stress of virus infection and arrest cap-dependent mRNA translation, which normally results in
the formation of cytoplasmic aggregates of translationally stalled mRNA-protein complexes known as stress granules (SGs).
It remains unclear how IAV ensures preferential translation of viral gene products while evading stress-induced translation
arrest. Here, we demonstrate that at early stages of infection both viral and host mRNAs are sensitive to drug-induced
translation arrest and SG formation. By contrast, at later stages of infection, IAV becomes partially resistant to stress-induced
translation arrest, thereby maintaining ongoing translation of viral gene products. To this end, the virus deploys multiple
proteins that block stress-induced SG formation: 1) non-structural protein 1 (NS1) inactivates the antiviral double-stranded
RNA (dsRNA)-activated kinase PKR, thereby preventing eIF2a phosphorylation and SG formation; 2) nucleoprotein (NP)
inhibits SG formation without affecting eIF2a phosphorylation; 3) host-shutoff protein polymerase-acidic protein-X (PA-X)
strongly inhibits SG formation concomitant with dramatic depletion of cytoplasmic poly(A) RNA and nuclear accumulation
of poly(A)-binding protein. Recombinant viruses with disrupted PA-X host shutoff function fail to effectively inhibit stress-
induced SG formation. The existence of three distinct mechanisms of IAV-mediated SG blockade reveals the magnitude of
the threat of stress-induced translation arrest during viral replication.
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Introduction
Transcription of Influenza A virus (IAV) genes is performed by
a viral polymerase that generates 59-capped and polyadenylated
(poly[A]) messenger RNAs (mRNAs) structurally similar to host
mRNAs [1]. Despite this similarity, IAV transcripts gain
preferential access to cellular translation machinery through a
host shutoff mechanism executed by the viral non-structural
protein 1 (NS1) [2,3] and the recently discovered viral PA-X
protein [4].
The reliance on cap-dependent translation initiation makes viral
mRNAs susceptible to host-cell stress-induced translation inhibi-
tion mechanisms. This inhibition results from phosphorylation of
eukaryotic translation initiation factor-2a (eIF2a) by any of four
kinases activated by distinct types of stress [5]. Heme-regulated
translation inhibitor (HRI) kinase is activated in response to
oxidative stress, GCN2 senses nutrient deprivation and ultraviolet
damage, double-stranded RNA (dsRNA)-dependent protein kinase
R (PKR) is activated in response to viral infections, and the PKR-
like endoplasmic reticulum kinase (PERK) signals in response to
endoplasmic reticulum stress. Inhibition of translation initiation
leads to runoff of elongating ribosomes from mRNA and the
accumulation of stalled translation preinitiation complexes.
Translationally inactive messenger ribonucleoproteins (mRNPs)
recruit RNA-binding proteins with self-aggregating properties,
including the T-cell intracellular antigen 1 (TIA-1), TIA-1-related
protein (TIAR), and ras GTPase-activating protein-binding
protein 1 (G3BP1), which nucleate the formation of large
cytoplasmic mRNP foci known as stress granules (SGs; [6]). Many
viruses have evolved specific mechanisms that modulate SG
responses (reviewed in [7]).
Previously we demonstrated that SGs do not form at any point
during IAV infection [8]. Importantly, complete inhibition of SG
formation is dependent on NS1. In cells infected with NS1-mutant
viruses, SG formation is triggered by PKR activation. However,
more than 50% of cells infected with NS1-mutant viruses
remained SG-free and allowed IAV replication cycle progression,
suggesting the existence of additional NS1-independent mecha-
nisms of SG suppression. In this work, by analyzing SG formation
in IAV-infected cells in response to a variety of stresses, we report
a robust mechanism of SG inhibition that becomes engaged at
later times post-infection and acts despite strong eIF2a phosphor-
ylation. Maximal SG inhibition coincided with a striking depletion
of cytoplasmic poly(A) mRNA and the nuclear re-localization of
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replication, effects reminiscent of host shutoff mechanisms
observed in other viral systems [9–11]. Screening of known IAV
ORFs derived from A/PuertoRico/8/34(H1N1) strain (PR8)
revealed the identities of two additional viral SG inhibitors,
nucleoprotein (NP) and polymerase-acidic protein-X (PA-X),
which both act independently of eIF2a phosphorylation. Further-
more, we provide evidence that in the early stages of infection,
before the accumulation of sufficient quantities of SG-inhibiting
proteins, viral replication is vulnerable to translation-inhibiting
drugs that induce SGs and block viral replication.
Results
Influenza A virus inhibits SG formation by an NS1-
independent mechanism
Previously we have observed SG formation triggered by
infection with recombinant influenza viruses with amino acid
substitutions in NS1 that compromise its ability to counteract PKR
[8]. For two different NS1 mutant viruses, SG formation peaked at
18 hpi; however, a majority of infected cells remained SG-free
throughout a 24 h time course, suggesting that either these cells
are not competent to form SGs, or that IAV has additional
mechanisms that block PKR activity and/or SG formation. To
test whether these infected cells are competent to form SGs, we
treated cells infected with either WT or NS1 mutant viruses with
sodium arsenite, a potent inducer of SGs that activates the
oxidative stress-responsive eIF2a kinase HRI [12]. By 18 hpi,
sodium arsenite had induced the formation of large, well-defined
SGs in the cytoplasm of all uninfected cells, while most of the cells
infected with either WT or NS1 dsRNA binding mutant viruses
failed to form SGs (Fig. 1A). We reinforced these observations
through use of an additional NS1-mutant virus whose NS1 protein
retains the functional dsRNA-binding domain but completely
lacks the C-terminal effector domain (PR8 NS1 N80; Fig. 1B
upper panel), and a mutant virus completely lacking functional
NS1 (PR8 NS1 N15). The latter virus triggered formation of
PKR-mediated SGs, but was still able to partially inhibit arsenite-
induced SG formation at 18 hpi (Fig. 1B lower panel, and Fig. 1D).
We observed striking inhibition of arsenite-induced SGs in WT
PR8-infected cells from 12 hpi onwards, peaking at 18 hpi
(Fig. 1C). For this reason, we evaluated a panel of NS1-mutant
viruses at this time point (Fig. 1E). These NS1 mutant viruses,
while triggering SG formation to varying degrees in infected cells,
all inhibited arsenite-induced SGs compared to mock-infected
cells. Furthermore, this effect was not cell-line specific, as we
observed the same magnitude of SG inhibition by PR8 in U2OS
osteosarcoma cells (Fig. S1A–M). Importantly, SG inhibition did
not result from blockade of arsenite-induced eIF-2a phosphory-
lation (Fig. S1N), and the levels of SG constituent proteins TIA-1,
G3BP, PABP1 and eIF4A did not change throughout a 24 h
infectious cycle (Fig. S1O).
What is the significance of SG inhibition at later times post-
infection? Using pulse-labeling experiments, we queried the rate of
viral protein synthesis and sensitivity to sodium arsenite treatment.
We observed a high rate of viral protein synthesis, which was
maintained at later times post-infection (Fig. 1F lanes 1–4).
Sodium arsenite treatment inhibited the production of viral
proteins at 6 hpi and 16 hpi; however, the remaining translation
rate was significantly higher at 16 hpi (Fig. 1F, G), coincident with
SG inhibition. Collectively, our data suggest that at later times
post-infection the virus establishes an environment in which
accumulation of viral proteins becomes less sensitive to stress-
induced translation arrest.
SG inhibition is independent of vRNP export and
coincides with depletion of cytoplasmic poly(A) RNA
At later times post-infection, IAV vRNPs are exported from
the nucleus to the cytoplasm and transit to the cell surface for
assembly and egress. We observe inhibition of SG formation
late in infection, coincident with the cytoplasmic export of
vRNPs. To test whether cytoplasmic accumulation of vRNPs is
necessary for SG inhibition, we treated mock- and IAV-
infected cells with leptomycin B (LMB), an inhibitor of CRM1-
dependent nuclear export. Consistent with previous reports
[13], LMB treatment prevented cytoplasmic accumulation of
vRNPs (Fig. 2A). Importantly, in our system LMB treatment
did not affect SG inhibition in virus-infected cells, and
did not alter SG formation in mock-infected cells. Thus,
cytoplasmic localization of vRNPs is dispensable for SG
inhibition.
Because SGs are comprised of stalled poly(A) mRNAs and
certain translation initiation factors, we determined their intracel-
lular location at late times post-infection. We saw a remarkable
relocalization of PABP1 to the nucleus of infected cells (Fig. 2B).
PABP1 is nucleocytoplasmic shuttling protein that binds newly
polyadenylated mRNAs in the nucleus [14]. Thus, the nuclear
accumulation of PABP1 strongly suggested that the normal
processing and transport of nascent mRNAs is impaired in
infected cells, and/or cytoplasmic mRNA pools are severely
depleted. Using fluorescence in situ hybridization (FISH), we
analyzed the nucleocytoplasmic localization of poly(A) mRNA at
early and late times post-infection. Subcellular distribution of
poly(A) RNA was comparable in mock- and IAV-infected cells at
early times post-infection (Fig. 2C and S2). By contrast, at later
stages post-infection, we observed striking loss of poly(A) RNA
signal from the cytoplasm, and a noticeable increase in the
nuclear poly(A) signal (Fig. S2). Importantly, upon arsenite
treatment of mock- and IAV-infected cells at early times post-
infection, bright cytoplasmic poly(A) foci were observed, consis-
tent with the accretion of mRNAs into SGs. By contrast, no
Author Summary
Like all viruses, Influenza A virus (IAV) is absolutely
dependent on host-cell protein synthesis machinery. This
dependence makes the virus vulnerable to the innate
ability of cells to inhibit protein synthesis in response to
various types of stress. This inhibition, termed translation
arrest, helps cells survive adverse conditions by re-
dedicating their energy to stress responses. When cells
arrest translation, they form stress granules: depots of
untranslated mRNAs and associated proteins. Translation
arrest and formation of stress granules can be induced
pharmacologically, and in this work we sought to
determine whether stress granule induction would be
effective in blocking IAV replication. Here we demonstrate
that treatment of cells with inducers of stress granules at
early times after infection resulted in blockade of viral
protein synthesis and stopped viral replication. At later
times post-infection, by contrast, IAV proteins prevented
pharmacological induction of stress granules. We identi-
fied three viral proteins – more than in any virus to date –
that work in concert to prevent stress granule formation.
Taken together, our studies reveal a multipronged
approach for viral suppression of translation arrest, and
identify a window of opportunity early in infection when
pharmacological induction of stress granules has a strong
antiviral effect.
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accumulation of poly(A) RNA. Taken together, these data suggest
that IAV SG inhibition coincides with bulk depletion of
cytoplasmic poly(A) mRNA and the nuclear accumulation of
PABP1.
Influenza A virus inhibits SG formation downstream of
eIF-2a kinase activation
In eukaryotes, eIF2a integrates signals from four stress-activated
kinases, and we have established that IAV inhibits SG formation in
response to either HRI- or PKR-mediated eIF2a phosphorylation.
Figure 1. Influenza A virus inhibits sodium arsenite-induced SG formation at later times post-infection by an NS1-independent
mechanism. (A and B). SG formation was analysed using immunofluorescent staining of A549 cells infected with the wild type (PR8) and the
indicated NS1-mutant influenza A viruses treated with sodium arsenite (As) at 18 hours post-infection (hpi). Virus-infected cells were identified by
antibody staining for NP (green) and SGs were visualized using staining for TIA-1 (red). In panel (B) nuclei were stained with DAPI (blue). Scale bars
represent 20 mm. (C) Virus and arsenite-induced SG formation was quantified in A549 cells infected with WT PR8 virus at 6, 12, 18 and 24 hours post-
infection (hpi). (D) Same quantification as in (C) was done in cells infected with PR8 NS1 N15 virus. (E) SG formation at 18 hpi was compared in mock-
infected cells and cells infected with recombinant PR8 viruses with the indicated NS1 mutations. (F) Autoradiogram of the whole cell lysates of mock
and PR8 virus-infected A549 cells. At 6 or 16 hpi cells were either left untreated (-) or treated with sodium arsenite (+As) for 1 hour and then
immediately pulse-labelled with [
35S]methionine-[
35S]cysteine for 30 min. (G) Viral NP and HA translation rates post-arsenite treatment are compared
between 6 and 16 hpi. Band intensities after arsenite treatment from (F) were normalized to untreated sample band intensities.
doi:10.1371/journal.ppat.1004217.g001
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phosphorylation, we assessed SG formation triggered by thapsi-
gargin and UV light, which activate the two remaining eIF2a
kinases, PERK and GCN2, respectively. As a control, we also
tested pateamine A (PatA), which has been shown to induce SGs
by translation inhibition but without eIF2a phosphorylation [15]
(Fig. 3A–C). In mock-infected cells, these treatments induced
varying degrees of SG formation. Nevertheless, consistent with our
sodium arsenite data, IAV inhibited SG formation in response to
all three treatments without affecting eIF2a phosphorylation
(Fig. 3A–C). Most notably, IAV inhibited SG formation in
response to PatA treatment, which did not induce eIF2a
phosphorylation. Together, these findings establish that IAV can
block SG formation in a manner independent of eIF2a
phosphorylation.
Influenza A virus PA and NP ORFs inhibit SG formation
To identify additional IAV gene products that could function in
this NS1-independent mechanism of SG inhibition, we analyzed
arsenite-induced SG formation in cells ectopically expressing myc
epitope-tagged constructs for each of the known IAV ORFs
(Fig. 4A). Among 11 ORFs analyzed, only PA and NP significantly
inhibited arsenite-induced SG formation. PA-myc was predomi-
nantly localized to the cytoplasm, consistent with requirement of
the PB1 viral subunit for its nuclear import [16]. In cells in which
PA failed to suppress SG formation, PA-myc maintained a diffuse
cytoplasmic localization and was not recruited to SGs (Fig. 4A). By
contrast, NP was found predominantly in the nucleus of
transfected cells, with only a fraction of the total signal coming
from the cytoplasm. NP-mediated inhibition of SG formation was
dependent on NP expression level (Fig. S3), and many cells with
low levels of NP formed SGs upon arsenite treatment. In cells in
which NP failed to inhibit SG formation, NP was recruited to SGs,
consistent with previous reports [17]. Finally, NS1 and the viral
protein M1 were similarly recruited to arsenite-induced SGs, but
did not interfere with their formation (Fig. 4B). The distinct
subcellular distribution and SG-recruitment characteristics of PA
and NP suggested distinct mechanisms of SG suppression.
Importantly, in cells expressing high levels of PA, SG inhibition
coincided with striking relocalization of PABP1 to the nucleus
(Fig. 4B), similar to what we observed in IAV-infected cells at late
times post-infection (Fig. 2B). Importantly, in both PA-transfected
Figure 2. vRNP export-independent SG inhibition by influenza
virus coincides with depletion of cytoplasmic poly(A) RNA and
nuclear relocalization of PABP1. (A and B) Immunofluorescent
analysis of mock and PR8 virus-infected cells at 18 hpi, treated with
sodium arsenite where indicated. (A) At 6 hpi some A549 cells received
10 ng/ml leptomycin B (+LMB) to block nuclear export of viral
ribonucleoproteins up to the time of arsenite treatment and
subsequent fixation at 18 hpi. SG formation was analysed by staining
for TIA-1 (red) and YB-1 (green) markers and viral ribonucleoproteins
were detected with antibody to NP (blue). (B) SG formation and sub-
cellular distribution of cellular G3BP, eIF3A (red), PABP1 (PABP, green),
and influenza virus proteins (IAV, blue) were analysed in U2OS and A549
cells. Note that while in U2OS cells most of the IAV antigens remain
nuclear at 18 hpi, virus material is exported from the nucleus by this
time point in A549 cells (open arrows). In both cell lines, however, virus
causes redistribution of PABP1 to the nucleus and the SG formation is
blocked (filled arrows). (C) Sub-cellular distribution of poly(A) RNA in
mock and PR8 virus-infected A549 cells was analysed at indicated times
post-infection by fluorescence in situ hybridization. At 18 hpi, many
PR8-infected cells have decreased cytoplasmic and increased nuclear
poly(A) signal. Upon arsenite treatment (+As) these cells fail to form
cytoplasmic poly(A) RNA-containing stress granules (arrows). Scale
bars=20 mm.
doi:10.1371/journal.ppat.1004217.g002
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coincided with complete inhibition of SG formation in all our
experiments. To confirm that both PA and NP interfere with SG
formation regardless of eIF2a phosphorylation, we tested PatA-
induced SG formation in cells expressing these IAV ORFs
(Fig. 4C,D). Both proteins were able to block SG formation in
response to PatA. NS1, as expected for this PKR-specific SG
inhibitor, did not interfere with arsenite- and PatA-induced SG
formation (Fig. 4A–D).
NP oligomerization is required for efficient SG inhibition
NP associates with IAV genomic and anti-genomic segments
and is essential for vRNP synthesis, genome trafficking and virus
assembly [18]. Extensive mutational analysis and atomic-resolu-
tion structural studies have identified important structural features
of NP, including an amino-terminal nuclear-localization signal
(NLS) and a carboxy-terminal oligomerization motif [19–21], both
critical for NP interaction with nascent vRNPs in the nucleus
(Fig. 5C). Mutation of arginine 8 to an alanine residue (R8A)
prevented nuclear localization of NP, but did not impair its ability
to suppress arsenite-induced SG formation, suggesting that NP
nuclear accumulation is not required for SG inhibition (Fig. 5A,
B). NP oligomerization was experimentally disrupted by substitu-
tion of key resides in the tail loop (F412A, R416A) required for the
formation of intermolecular salt bridges [19,20]. Disruption of NP
oligomerization completely restored arsenite-induced SG forma-
tion in transfected cells (Fig. 5A, B). During infection, NP
oligomerization is essential for polymerase activity and for the
stability and transport of vRNPs, but our experiments clearly
demonstrate that NP-mediated inhibition of SG formation is
independent of virion RNAs or polymerase subunits. NP has not
been shown to interact with host RNAs, but a number of high-
affinity interactions of IAV ribonucleoproteins with host factors
have been identified [22], many of which could plausibly be
dependent on the ability of NP to oligomerize.
PA-X mediated depletion of cytoplasmic mRNA coincides
with SG inhibition
Influenza virus infection results in the rapid decline of host
protein synthesis, a process referred to as shutoff. The viral PA
protein has been implicated in this host shutoff, but the
mechanism remained obscure until the recent discovery of an
additional protein, PA-X, produced from the PA gene by
ribosomal frameshifting [4] (Fig. 6F). PA-X was shown to inhibit
cellular gene expression and modulate viral virulence and the
global host response [4,23]. The PA-myc plasmid shown above to
inhibit arsenite-induced SG formation and cause nuclear accu-
mulation of PABP1 is predicted to also encode PA-X (Fig. 4). To
determine whether the full-length PA protein, or the alternative
PA-X protein product, is responsible for SG inhibition and PABP1
relocalization, we transiently transfected HeLa Tet-Off cells with a
carboxy-terminal epitope-tagged PA expression vector, or the
same construct with optimized codons for F191 and R192 that
would greatly reduce the probability of frameshifting and PA-X
production (PA(fs)-myc), or a frameshift mutant constructed to
express PA-X exclusively (PA-X, Fig. 6F). Results with these
plasmids strongly indicate that the PA-X protein produced as a
result of ribosomal frameshifting is responsible for the SG
inhibition and PABP1 relocalization observed in PA-myc trans-
fected cells. In cells transfected with the PA-X construct, we
observed the strongest nuclear accumulation of PABP1, which was
completely concordant with SG inhibition. By contrast, in PA(fs)-
myc transfected cells, we could not detect any relocalization of
PABP1, and arsenite-induced SG formation was unperturbed. As
Figure 3. Influenza A virus blocks SG formation independent of
inducing stimuli and downstream of eIF2a phosphorylation. SG
formation and eIF2a phosphorylation was analysed in mock and PR8
virus infected A549 and U2OS cells at 18 hpi by immunofluorescent
staining and western blot. Cells were either left untreated (-), treated for
1 hour with pateamine A (PatA), treated for 1 hour with thapsigargin
(Tg), or exposed to UV light and incubated for 2 hours (UV) prior to
analysis. (A) Immunofluorescent staining with antibodies to influenza A
virus (IAV, red) and TIAR (red). Scale bars=20 mm. (B) SG formation was
quantified from the experiment presented in (A). (C) Western blot
analysis of the whole cell lysates of A549 and U2OS cells treated as in
(A).
doi:10.1371/journal.ppat.1004217.g003
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phenotype, consistent with a lower expected level of PA-X
production (Fig. 6B). To directly confirm that PA-X ORF is
expressed in cells showing nuclear PABP relocalisation, we created
an additional expression construct with a C-terminally tagged PA-
X ORF. Due to high toxicity of PA-X, only cells expressing low
levels of this fusion protein remained viable at 24 h post-
transfection. Nevertheless, these levels were sufficient to cause
nuclear relocalisation of PABP1 and complete blockade of SG
formation in response to arsenite treatment (Fig. S4). In the study
by Jagger et al. (2012), PA-X expression was linked to host gene
expression shutoff, which required an endonuclease function of the
N-terminal domain shared by the full-length PA and PA-X
proteins (Fig. 6F). It was proposed that this endonuclease activity
of PA-X is responsible for depletion of host cytoplasmic mRNA
pools. To determine whether PA-X endonuclease activity is
responsible for depletion of cytoplasmic PABP1 (Fig. 2B) and
poly(A) mRNA (Fig. 2C) late in IAV infection, we disrupted the
endonuclease activity of PA and PA-X by a single amino acid
substitution at D108 (PA(108A)-myc), and analyzed SG formation
and subcellular distribution of poly(A) RNA using FISH (Fig. 6A,
D). Similar to PA(fs)-myc transfected cells, cells transfected with
PA(108A)-myc displayed normal cytoplasmic levels of poly(A)
RNA and formed SGs in response to sodium arsenite.
To examine the contribution of PA-X to the SG-inhibition
phenotype at late times post-infection, we created a recombinant
IAV with a codon-optimized PA ORF, termed PR8 PA(fs),
expected to have an attenuated host-shutoff phenotype [4]. At
18 hpi, the PR8 PA(fs) infected cells showed dramatically
decreased nuclear PABP1 relocalization and attenuated SG
inhibition in response to sodium arsenite (Fig. 6C, E). Notably, a
fraction of cells infected with PR8 PA(fs) remained refractory to
arsenite-induced SG formation, perhaps due to inhibition of SG
formation by NP protein.
Pateamine A induces SG formation and blocks influenza
A virus replication
We have established that at later stages of its replication cycle
IAV efficiently blocks SG formation downstream of eIF2a
Figure 4. Ectopic expression of influenza A virus PA and NP ORFs inhibits SG formation induced by arsenite and pateamine A. HeLa-
TetOff cells were transfected with the expression vectors for the indicated c-terminally myc-tagged IAV ORFs or the EGFP or mRFP expression vectors
and treated with sodium arsenite or PatA 24 hours post-transfection. 50 min post-treatment SG formation was analyzed by immunofluorescent
staining for TIA-1 or TIAR and SG co-localization of viral ORF-encoded proteins by staining for myc epitope. (A). Arsenite-induced SG formation (dark
grey bars) and SG recruitment (double-positive SGs, light grey bar overlays) was quantified from 3 independent experiments. (B). Representative
immunofluorescence images demonstrating arsenite-induced SG inhibition by PA-myc and NP-myc (arrows), SG co-localization of M1-myc and NS1-
myc proteins (circles), and nuclear PABP1 relocalization in PA-myc expressing cells. (C). PatA-induced SG formation (dark grey bars) and SG
recruitment (double-positive SGs, light grey bar overlays) in cells expressing the indicated IAV ORFs and the control mRFP protein was quantified
from 2 independent experiments. (D). Representative immunofluorescence images demonstrating SG inhibition by PA-myc and NP-myc (arrows) in
response to PatA treatment, and SG co-localization of NS1-myc protein (circles).
doi:10.1371/journal.ppat.1004217.g004
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sensitive to treatments that induce translation arrest and SG
formation (Fig. 1C, F). This early part of the infectious cycle may
therefore provide a window of opportunity for pharmacological
induction of viral translation arrest and SG formation. Among the
treatments that we have tested, we observed strongest induction of
SG formation in response to sodium arsenite (Fig. 1) and PatA
(Fig. 3). To test the effects of these drugs on viral replication, we
pulse-treated IAV-infected cells at 4 hpi, with subsequent removal
of drug after 1 h. This 1 h treatment with PatA was sufficient to
completely block IAV replication, as evidenced by lack of
accumulation of viral proteins at later times post-infection
(Fig. 7A). Interestingly, sodium arsenite had minimal effects on
IAV protein accumulation. Despite the high toxicity of sodium
arsenite, upon its removal cells are reported to rapidly dephos-
phorylate eIF2a, dissolve SGs, and resume robust translation [24].
By contrast, PatA binds and inhibits the function of eIF4A helicase
irreversibly [25]. These properties could explain the differential
effect of these SG-inducing agents on viral replication. To test this,
we compared translation rates in mock- and PR8-infected cells
immediately post-treatment with sodium arsenite or PatA, and at
regular intervals post-drug withdrawal. As shown in Fig. 7B, D,
soon after removal of sodium arsenite, production of IAV proteins
was largely restored. By contrast, translation rates remained low
long after PatA was removed (Fig. 7C, D). This sustained
inhibition is in agreement with lack of viral protein accumulation
up to 14 hours after removal of PatA-containing medium (Fig. 7A),
and is marked by the accumulation and persistence of SGs, both in
mock- and PR8-infected cells (Fig. 7F). Importantly, persistence of
SGs prevented the accumulation of progeny vRNPs in the
cytoplasm (Fig. 7F), viral genomic RNA accumulation (Fig. 7G),
and infectious virus production (Fig. 7E). By contrast, PatA
treatment did not prevent viral mRNA accumulation, and even
increased its abundance at later times post-infection (Fig. 7H). This
finding is consistent with the model in which viral replication is
dependent on de novo protein synthesis [26], and earlier observa-
tions that treatment with translation inhibitors prevents viral
polymerase from initiating genome replication while still allowing
viral mRNA synthesis [27].
Given the potency of PatA for IAV inhibition, we tested the
effects of low-dose PatA treatment on multi-round IAV infection
and observed an inhibitory effect at 2 and 0.4 nM (Fig. 7I). It is
notable that we observed no adverse effects of PatA on cell
viability at these low doses, consistent with published observations
in other model systems [28].
Discussion
Despite being generated by a viral RNA-dependent RNA
polymerase complex, IAV mRNAs bear structural similarity to the
products of host RNA polymerase II, with 59 caps and 39 poly(A)
modifications that ensure efficient translation by host machinery
[1]. These features render IAV mRNAs susceptible to negative
regulation by eIF2a kinases that have evolved to sense a variety of
environmental stresses, including viral infection [5]. Triggering of
eIF2a phosphorylation during IAV infection would therefore be
expected to arrest translation of a large fraction of viral mRNAs as
well as host mRNAs, and entrap them in SGs. Remarkably, we
observed that SGs do not form at any point during the IAV
replication cycle and efficient translation of viral gene products is
maintained in the later stages of infection, when a variety of eIF2a-
kinase activating signals might be anticipated. Here we have
Figure 5. NP oligomerisation is required for SG inhibition. (A and B). HeLa-TetOff cells were transfected with the expression vectors for the
indicated wild-type and mutant NP proteins and treated with sodium arsenite 24 hours post-transfection. 50 min post-treatment sub-cellular
distribution of NP constructs (green) and SG formation (TIAR, red) was analyzed by immunofluorescent staining (A) and quantified (B). (C). Schematic
representation of NP protein showing selected primary sequence features (color shading) and positions of amino acids mutated in this study. Unlike
N-terminal nuclear localization signal (NLS1), downstream NLS (NLS2) is believed to be non-functional in the folded protein. The cytoplasmic
accumulation sequence (CAS) harbours residues that participate in oligomerisation.
doi:10.1371/journal.ppat.1004217.g005
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PLOS Pathogens | www.plospathogens.org 7 July 2014 | Volume 10 | Issue 7 | e1004217Figure 6. Viral PA-X protein participates in SG inhibition by depleting host cytoplasmic mRNAs. (A, B, D) HeLa-TetOff cells were
transfected with the indicated expression vectors and treated with sodium arsenite 24 hours post-transfection. (A) Sub-cellular distribution of poly(A)
RNA was analyzed by fluorescence in situ hybridization (green). Expression of the full-length wild type and mutant PA constructs was detected by
subsequent immunofluorescent staining for myc epitope (red). (B) SG formation (TIA-1, red) and sub-cellular distribution of PABP1 (PABP, green) was
analyzed by immunofluorescent staining. (D) SG formation was quantified from experiments described in (A). (C and E) Immunofluorescent analysis of
sodium arsenite-treated mock, wild-type (PR8), and recombinant PA-X deficient (PR8 PA(fs)) virus-infected A549 cells reveals that PA-X expressioni s
required for nuclear PABP1 relocalization and efficient SG inhibition (18 hpi). (C) Representative images showing strong SG inhibition and nuclear
PABP1 relocalization in the wild-type, but not the PR8 PA(fs) mutant virus-infected cells treated with sodium arsenite at 18 hpi. (E). Quantificationo f
SG formation and nuclear PABP1 localization from (C). (F). Schematic representation of PA and PA-X proteins synthesized from the same segment 3
transcript and sharing first 191 amino-acids encompassing the endonuclease domain. Continued ORF translation (frame 0, green) produces full-
length viral polymerase subunit PA, while +1 frameshifting at F191 codon (frame +1, red) produces smaller PA-X protein. Position of D108 residue that
is required for endonuclease activity of PA and PA-X is indicated on the diagram. To the right, frame shift site sequences mutagenized in this study
are presented. Note that single nucleotide deletion in PA-X construct completely prevents full-length PA protein expression, as evidenced by the lack
of myc-tag detection in the right column of panel (A).
doi:10.1371/journal.ppat.1004217.g006
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NS1, NP and PA-X (Fig. 8). NS1 binds to viral dsRNA and
prevents PKR activation and consequent eIF2a phosphorylation.
High levels of oligomeric NP block SG formation in an eIF2a-
independent manner, through a yet to be identified mechanism.
By contrast, inhibition of SG formation by PA-X, the alternative
product of PA mRNA that is made as a result of translational
frameshifting, is dependent on its endoribonuclease activity, and
coincides with depletion of a large fraction of cytoplasmic poly(A)
RNA. During PA mRNA translation, less than 2% of the
ribosomes frame-shift at the Phe-191, downstream of the
endoribonuclease domain that is shared between PA and PA-X
proteins [4]. This low rate of frame-shift ensures slow accumula-
tion of PA-X, the potent shutoff factor that acts at later times post-
infection. Indeed, mutations that inhibit frame-shifting and PA-X
production by IAV disrupt the viral inhibition of host gene
expression [4]. Our finding that PA-X inhibits SG formation led
us to explore PA-X host shutoff function, and our findings support
the recently proposed model; we find that PA-X causes striking
depletion of poly(A) RNA from the cytoplasm of cells transfected
with a PA-X expression vector, or in IAV-infected cells late in
infection, but not in cells infected with a mutant virus with defects
in PA-X protein production. Notably, in addition to the depletion
of cytoplasmic poly(A) RNA and nuclear relocalization of PABP1,
we also observe a remarkable accumulation of poly(A) RNA in the
nuclei of cells expressing PA-X and in virus-infected cells at later
times post-infection. While this phenomenon has not been
demonstrated previously for IAV infections, a similar accumula-
tion of poly(A) RNA and PABP1 has been reported in other viral
infections, and in each case the described perturbations of PABP1
has been linked to host shutoff [9–11]. For example, host shutoff in
cells infected by Kaposi’s sarcoma-associated herpesvirus (KSHV)
is enforced by the shut-off exonuclease protein SOX, which
accumulates during infection and degrades host cytoplasmic
mRNAs [29]. SOX expression leads to strong nuclear accumu-
lation of PABP1 and hyper-adenylated mRNAs. It was demon-
strated that relocalization of PABP1 to the nucleus results in
stimulation of poly(A) polymerase and synthesis of extended
poly(A) tails [30]. Given the general inhibition of host mRNA
synthesis by IAV, it is plausible that an increase in nuclear poly(A)
RNA signal is due to hyperadenylation rather than a blockade of
nascent mRNA export, similar to the hyperadenylation observed
in cells ectopically expressing KSHV SOX protein or a mutant
PABP1 that is restricted to the nucleus [31]. PABP1 localizes to
SGs, but is not required for SG formation [6,32]. Therefore, it
remains to be determined whether PA-X directly affects nucleo-
cytoplasmic shuttling of PABP1, or whether PABP1 nuclear
accumulation simply results from bulk depletion of cytoplasmic
poly(A) RNA. In either case, we have demonstrated here that the
endonuclease activity of PA-X is important for SG inhibition,
forging the first links between host shutoff and SG dynamics.
Host shutoff is an important feature of influenza virus infection.
In human-adapted strains of IAV, host shutoff is mediated at least
in part by the NS1 proteins that are able to bind and inactivate the
cellular cleavage and polyadenylation specificity factor 30
(CPSF30). This inactivation prevents polyadenylation and nuclear
export of host pre-mRNAs [2]. The host shutoff mechanisms
employed by IAV strains with NS1 proteins that lack CPSF30-
binding activity remain poorly characterized, but the recent
discovery of the PA-X protein significantly advances our
understanding of host shutoff by these viruses. Curiously, our
study reveals that PA-X expression causes nuclear accumulation of
poly(A) RNA, which would require polyadenylation of at least
some RNA species in the nucleus. At present, we cannot predict
the cumulative effects on sub-cellular poly(A) RNA distribution of
CPSF30 inactivation by NS1 and nuclear PABP1 relocalization by
PA-X, because the NS1 of PR8 strain employed in this study does
not bind CPSF30. Interestingly, the PA segment of WSN/33
strain of IAV, which is competent for CPSF inactivation, was less
effective at inhibiting host protein synthesis than the PA segment
from A/California/04/2009 strain [23]. This difference suggests
that the host-shut-off function of PA-X, similar to that of NS1,
may vary significantly between strains of IAV.
NP is a highly conserved RNA-binding protein that plays
essential roles in IAV transcription, genome replication, and
genome packaging into nascent virions. NP binds to RNA with
high affinity (Kd approx. 20 nM), but there is little evidence for
sequence specificity, and no links have yet been made to the
control of mRNA translation [33,34]. Our data demonstrate that
ectopic expression of NP alone, in the absence of viral RNA or
other viral proteins, is sufficient to inhibit arsenite-induced SG
formation. Structural studies have shown that NP forms oligomers
in physiological ionic conditions [19]. The formation of these
oligomers depends on intermolecular salt bridges, and we
demonstrate that experimental disruption of these salt bridges by
substitution of key residues in the tail loop (F412A, R416A)
disabled the SG-inhibition function of NP. We are unable to assess
the impact of these mutations on NP function during viral
infection because they prevent IAV transcription and genome
replication [35]. Proteomic studies have identified a number of
host proteins bound by viral ribonucleoproteins [22], several of
which play roles in mRNA processing, stability and translation. In
addition, a number of proteins recruited to SGs and involved in
their formation have been shown to bind NP [36,37,38]. NP
interacts with nuclear factor 90 (NF90) that participates in virus-
induced PKR activation and SG formation [38]. Another host
antiviral factor that is recruited to SGs and interacts with both NP
and NS1 is the RNA-associated protein 55 (RAP55) [36]. When
unable to block SG formation (e.g. at early times post-infection)
NS1 and NP can be sequestered in SGs by RAP55 where their
normal functions are likely to be inhibited. Thus, it is possible that
IAV NS1 and NP can be both the antagonists and the targets of
host antiviral SG responses. Recently, RNA-dependent interac-
tion of IAV NP with Fragile X mental retardation protein
(FMRP) was demonstrated and FMRP was shown to stimulate
viral ribonucleoprotein assembly [37]. Unlike the antiviral factors
NF90 or RAP55, FMRP contributes to efficient IAV replication,
and may be sequestered through recruitment to SGs. This would
further impair viral replication and contribute to the antiviral
effect of SGs. In our ongoing studies, we plan to employ WT and
mutant NP constructs to screen for interactions with these and
other host factors, and determine their relative impact on SG
dynamics.
We have established that early in infection, before significant
accumulation of NP and PA-X proteins, IAV is particularly
sensitive to treatments that induce translation arrest and SG
formation. This may provide a window of opportunity for
pharmacological induction of viral translation arrest and SG
formation. Among the treatments tested, we observed strongest
induction of SG formation in response to arsenite and to PatA.
Until now, PatA and related structural analogs have been
evaluated for their antitumor properties, and found to represent
promising and selective anti-tumor agents [39,40]. Like tumor
cells, IAV-infected cells require high levels of translation to support
their metabolic needs. Moreover, at the concentrations used in our
studies, PatA inhibits the translation of only a fraction of cellular
RNAs, specifically ones important for tumor cell growth and
metastasis [39]. Ongoing in vitro studies will address the
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inhibitor drugs in IAV restriction.
In summary, we report that translation of IAV proteins continues
uninterrupted until late in infection, long after the viral polymerase
complex has been re-tasked to viral genome replication. We report
the remarkable discovery of three functionally distinct IAV-
encoded inhibitors of SG formation, which together strongly
influence the translational landscape of infected cells. The
existence of three distinct mechanisms of IAV-mediated SG
inhibition reveals the magnitude of the threat (to the virus) of
Figure 7. Pateamine A treatment causes sustained arrest of viral protein and genomic RNA synthesis. (A). Effects of 1-hour arsenite and
pateamine A treatments on IAV protein accumulation. A549 cells were infected with PR8 virus and treated with either arsenite or pateamine A at
4 hpi. After 1 hour, drug-containing media was removed, cells were washed with PBS and received fresh media. Whole cell lysates were collected at
18 and 24 hpi and analysed by western blot. (B and C) Autoradiograms of the lysates of mock and PR8 virus-infected cells. At 3 hpi cells were either
left untreated (-) or treated with sodium arsenite (B) or pateamine A (C) for 1 hour and then pulse-labelled with [
35S]methionine-[
35S]cysteine
immediately after treatment and at the indicated 2-hour intervals. (D) Recovery of viral protein translation post-arsenite and post-pateamine A
treatments was quantified from autoradiograms in (B) and (C). Band intensities from post-treatment lanes were normalized to untreated sample band
intensities for each time point. (E to H). SG formation, viral RNA accumulation, and infectious virus production were analysed in mock and PR8 virus-
infected A549 cells treated with 10 nM pateamine A at 4 hpi. (E) Virus titers were analysed in culture media collected at 24 hpi by plaque assays. (F)
Cells were fixed and immunofluorescently stained for influenza NP (red) and TIAR (green) at indicated times post-infection (hpi). (G) Accumulation of
viral genomic RNA segment 8 was quantified by real-time quantitative RT-PCR. (H) Accumulation of viral NS1 mRNA was quantified by real-time
quantitative RT-PCR. (I) Pateamine A protects cells from influenza virus-induced cell death. Vero cells were inoculated with PR8 virus at MOI 0.1. After
1 h, inoculums were replaced with infection medium containing 2.5 mg/ml trypsin and the indicated concentrations of pateamine A, or control media
lacking trypsin (No tryps.). 2 days post-infection cells were fixed with 4% paraformaldehyde and stained with crystal violet (purple).
doi:10.1371/journal.ppat.1004217.g007
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hints that other viruses, large and small, may also encode
multiple SG-regulatory proteins. Investigation of the mecha-
nisms of action of these viral SG inhibitors may reveal
important clues about how these viruses enforce host shutoff
and ensure preferential production of viral gene products.
Materials and Methods
Reagents and cells
Unless specifically indicated, all chemical reagents were
purchased from Sigma. Pateamine A was a kind gift from Dr.
Jerry Pelletier (McGill University, Montreal, QC, Canada). HeLa-
TetOff cells were purchased from Clontech. A549, U2OS, Vero,
and HeLa-TetOff cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM; HiClone) supplemented with 10% fetal
bovine serum (FBS, Life Technologies) and 100 U/ml penicillin+
100 mg/ml streptomycin+20 mM L-glutamine (Pen/Strep/Gln;
Wisent) at 37uCi n5 %C O 2 atmosphere.
Viruses, infections and treatments
The A/PuertoRico/8/34/(H1N1) virus (PR8) and the recom-
binant mutant viruses PR8 NS1 38A,41A and PR8 NS1 96,97A
are described in [8]. To generate NS1 deletion mutant viruses PR8
NS1 N80 and PR8 NS1 N15, the plasmid encoding segment 8 of
PR8 [41] was subjected to Phusion PCR mutagenesis (Finnzymes/
Thermo Scientific) to introduce termination codons at amino acid
positions 81 and 16, respectively, in the NS1 open reading frame.
Resulting constructs were combined with 7 wild-type PR8
plasmids for rescue of the mutant viruses as described in [41],
producing PR8 mutants expressing either just the dsRNA binding
domain of NS1 (PR8 NS1 N80) or completely lacking functional
NS1 and expressing only 15 N-terminal amino acids shared
between NS1 and NEP upstream of the unaltered transcript splice
site (PR8 NS1 N15). Recombinant virus PR8 PA(fs) was generated
using the general approach described above. In the segment 3
rescue plasmid, sequence TTTCGT encoding Phe-191 and Arg-
192 of the PA ORF was substituted with the optimized codon
sequence TTCCGC to generate the recombinant virus with
strongly attenuated +1 ribosomal frame shifting during PA mRNA
translation. Mutagenesis primer sequences are available upon
request. Virus stocks used for experiments were produced and
titrated by plaque assays as described [8]. Genomic RNA segments
3 and 8 of each virus stock were verified by sequencing.
For virus infection experiments, unless specified otherwise,
infections were done at multiplicity of infection (MOI) of 0.5. After
inoculation, cells received infection medium containing 0.5%
bovine serum albumin (BSA) in DMEM and incubated at 37uCi n
5% CO2 atmosphere. When indicated, mock and virus-infected
cells were treated with 0.75 mM sodium arsenite, 10 nM
pateamine A (except when other concentrations are given), or
1 mM Thapsigargin. For UV treatment, cells were washed briefly
with PBS, exposed to 10,000 mJ/cm
2 of 254 nm light in HL-2000
Hybrilinker chamber (UVP) and promptly returned to 37uC
incubator.
Plasmids and primers
Rescue plasmids encoding 8 segments of PR8 virus (pHW191-
PB2 to pHW198-NS) were kindly provided by Dr. Richard Webby
(St. Jude Children’s Research Hospital, Memphis, TN, USA).
pCR3.1-Myc and pCR3.1-NS1-myc expression vectors are
described in [8]. Remaining expression vectors for c-terminally
tagged PR8 ORF library (with the exception of M2) were
constructed by inserting PCR-amplified coding sequences from
the rescue vectors between KpnI and Mlu sites of pCR3.1-Myc
vector (flanking restriction sites were introduced by PCR). M2
expression vector was generated by removal of the intervening
intron sequence from pHW197-M plasmid using Phusion PCR
mutagenesis protocol. Untagged NP expression vector was
generated by inserting the PCR-amplified coding sequences from
the pHW195-NP plasmid into pCR3.1 vector (Invitrogen/Life
Technologies) between EcoRI and XhoI sites. Subsequent
substitutions in the NP ORF were done by PCR mutagenesis to
produce pCR3.1-NP(8A), pCR3.1-NP(412,416A) and pCR3.1-
NP(8,412,416A) vectors. pCR3.1-PA(fs)-myc, pCR3.1-PA(108A)-
myc and pCR3.1-PA-X were generated by PCR mutagenesis of
the pCR3.1-PA-myc vector from the PR8 ORF library. Cloning
primer sequences are available upon request.
Transient transfection
HeLa- TetOff cells were seeded at a density of 100,000 cells/
well of a 12-well culture plate and transfected the next day with
0.5 mg total DNA/well using FuGene HD reagent (Promega)
according to manufacturer’s protocol. At 24 h post-transfection,
cells were treated as described and analysed by immunofluorescent
staining.
Immunostaining
Cells grown on glass coverslips were fixed and immunostained
according to the protocol in [6] using mouse monoclonal
antibodies to IAV nucleoprotein (AAH5; Abcam), G3BP (clone
23, BD Transduction Labs), and PABP1 (sc-32318, Santa Cruz
Biotechnology); goat polyclonal antibody to TIA-1 (sc-1751, Santa
Cruz Biotechnology), influenza virus (ab20841, Abcam), rabbit
antibody to TIAR (clone D32D3, Cell Signaling), YB-1 (ab12148,
Abcam) and myc-tag (9B11; Cell Signaling) at manufacturer-
recommended dilutions. AlexaFluor-conjugated secondary anti-
bodies (Molecular Probes) were used at 1:1000 dilution. Images
were captured using Zeiss Axioplan II microscope or Zeiss LSM
510 laser scanning microscope. Quantification of stress granules
was done in at least 3 random fields of view with greater than 200
cells analysed on each slide. Cells were considered stress granule-
positive if two or more stress granule marker foci were present in
Figure 8. A model for concerted action of NS1, NP, and PA-X
proteins in the inhibition of translation arrest and SG
formation in influenza A virus-infected cells.
doi:10.1371/journal.ppat.1004217.g008
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resolved on denaturing 10% polyacrylamide gels and analyzed
using primary antibodies described above and the antibodies to
phospho-Ser-51- eIF2a (rabbit, D9G8, Cell Signaling), eIF4A
(goat, sc-14211, Santa Cruz Biotechnology), and actin (rabbit,
4968; Cell Signaling).
Isotopic labelling
As described in [8].
Fluorescence in situ hybridisation
Cells grown on glass coverslips were washed briefly with PBS,
fixed with 4% paraformaldehyde in PBS for 15 min at room
temperature, and permeabilized using 0.1% Triton X-100 in PBS
for 10 min. Coverslips were equilibrated in wash buffer (26SSC,
20% formamide, 0.02% BSA) for 15 min and then incubated
overnight with 100 ml of hybridization mix (wash buffer with 10%
dextran sulphate, 0.4 mg/ml S. cerevisiae tRNA, and 100 nM
Fluorescein-conjugated oligo-dT-40 probe) at 42uC. Then, cover-
slips were washed in wash buffer for 15 min at 42uC, for 15 min at
room temperature, and finally with PBS for 15 min prior to either
mounting on slides or blocking for subsequent immunostaining.
Real time quantitative PCR
Total RNA was isolated using the RNeasy mini-prep kit
(Qiagen) according to the manufacturer’s instructions, and the
cDNA synthesis was performed using the Super Script III Reverse
Transcriptase Kit (Life Technologies). Quantitative PCR analysis
was performed using MX6000P unit (Agilent Technologies) and
GoTaq PCR master mix (Promega). For analysis of NS1 mRNA
reverse transcription was performed using oligo-dT(20) primer.
For reverse transcription of segment 8 vRNA the following primer
was used: 59-CAA ACA CTG TGT CAA GCT TTC AG. Same
primer set was used for the mRNA and vRNA-derived cDNA
amplification: NS1-Left 59-CTG TGT CAA GCT TTC AGG
TAG A and NS1-Right 59- GGT ACA GAG GCC ATG GTC
AT. Relative initial template quantities were determined using the
standard curve method. For each biological replicate, reactions
were done in duplicate and mean cycle threshold (Ct) values were
used.
Statistical analyses
All error bars represent standard deviations calculated from
values obtained in at least 3 independent biological replicates.
Analysis of variance (ANOVA) single-factor algorithm was applied
to the select datasets using Microsoft Excel data analysis module
(Microsoft) to calculate p values. Where indicated, asterisks denote
p values lower than 0.05 (*) or 0.005 (**).
Supporting Information
Figure S1 Influenza A virus blocks SG formation in
response to sodium arsenite downstream of eIF2a
phosphorylation. Stress granule formation and eIF2a phos-
phorylation were analysed in mock and PR8 virus-infected U2OS
cells treated with sodium arsenite. (A to L) Immunofluorescent
staining for SG marker G3BP (red) and influenza virus antigens
(PR8, green) at indicated times post-infection (hpi). Uninfected and
some virus-infected cells that formed SGs in response to arsenite
are highlighted with arrows. (M) SG inhibition was quantified
from the experiment presented in panels (A–L). (N) Western blot
analysis of mock and PR8 virus-infected U2OS cells treated with
sodium arsenite at indicated times post-infection. (O) Western blot
analysis of cellular translation factors expression in PR8 virus-
infected cells at indicated times post-infection.
(TIF)
Figure S2 Inhibition of SG formation in IAV-infected
cells correlates with the redistribution of poly(A) RNA to
the nucleus and the decrease in host mRNA levels. (A and
B). Cytoplasmic and nuclear poly(A) RNA fluorescence in situ
hybridization signal in untreated and arsenite-treated mock and
PR8-infected A549 cells was measured using Image J software
(imagej.nih.gov). Outlines for the cytoplasm and the nucleus of
each individual cell were selected manually and the mean signal
intensities for the green channel were quantified. At least 3 images
of randomly-selected fields of view were used to quantify signals
from 15 cells in each category. Because only some PR8-infected
cells formed SGs after arsenite treatment at 18 hpi, cells that
formed SGs at 18 hpi and those that remained SG-free were
grouped in two separate categories. (A). No significant changes in
either cytoplasmic (left panel) or nuclear (middle panel) signal
intensities were observed between mock-infected and PR8-infected
cells at 6 hpi. Similarly, the ratios between nuclear and
cytoplasmic signals determined for each cell (right panel) did not
change significantly between these categories. By contrast,
significant reduction of cytoplasmic signal and corresponding
increase in nuclear signal was observed in infected cells at 18 hpi
compared to mock-infected cells. Importantly, at 18 hpi, in cells
that did not form SGs upon arsenite treatment, cytoplasmic signals
were significantly lower, and the nuclear signals were significantly
higher, than in cells that formed SGs. (B) Untreated (top panel)
and arsenite-treated (lower panel) PR8-infected cells at 18 hpi,
analysed by fluorescence in situ hybridization for subcellular
distribution of poly(A) RNA. Representative outlines of nuclear
(Nuc.) and cytoplasmic (Cyt.) areas used to measure mean signal
intensities presented in panel (A) are shown for some cells. Filled
arrows indicate cells that had measurable redistribution of poly(A)
RNA signal to the nucleus (nuclear to cytoplasmic ratio above 2.5)
and did not form SGs upon arsenite treatment. Cells that formed
arsenite-induced SGs are indicated with open arrows. Scale
bars=20 mm. (C). Levels of host actin and tubulin mRNAs, as well
as viral NS segment vRNA, were compared by RT-qPCR in PR8-
infected cells between 6 and 18 hpi. Values for host transcripts
were plotted relative to levels in mock-infected cells, whereas NS
vRNA levels were plotted relative to 6 hpi. All values were
normalized to total RNA levels. Primers for amplification of host
actin and tubulin cDNAs were ACTB-Left: 59-CAT CCG CAA
AGA CCT GTA CG; ACTB-Right 59-CCT GCT TGC TGA
TCC ACA TC; TUBB-Left: 59-TCT ACC TCC CTC ACT
CAG CT; and TUBB-Right: 59-CCA GAG TCA GGG GTG
TTC AT. Primers for NS vRNA reverse transcription and qPCR
amplification are described in Materials and methods. (D). RNA
harvested at the indicated time points was visualized using
denaturating agarose gel electrophoresis and ethidium bromide
staining. 28S and 18S rRNA band intensities were used for
normalization of RT-qPCR data presented in (C).
(TIF)
Figure S3 Inhibition of arsenite-induced SG formation
by NP correlates with its expression level. (A). A
representative image of HeLa-TetOff cells transfected with
influenza NP expression vector and treated with sodium arsenite
24 h post-transfection. SG formation was visualized by staining
with rabbit anti-eIF3A antibody (D51F4, Cell Signaling, red), and
NP expression levels were revealed by staining with mouse anti-NP
antibody (AAH5, Abcam, green). Cells that express high levels of
NP (filled arrows, numbered 1 to 4) failed to form SGs. Cells with
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low levels of NP (open arrowheads, numbered 8 and 9), and the
non-expressing cell (number 10) formed SGs in response to
arsenite. Scale bars=20 mm. (B). NP immunofluorescence signal
was measured and plotted for each of the numbered cells on panel
(A). Measurement procedure was done using Image J software as
described in the legend for figure S2 panels A and B, except the
mean signal intensity was determined for the entire cell (nucleus+
cytoplasm).
(TIF)
Figure S4 Low levels of PA-X expression are sufficient
for SG inhibition and nuclear relocalization of PABP.
HeLa-TetOff cells transiently transfected with the indicated
expression constructs were treated with sodium arsenite at
24 hpi, and immunostained with anti-TIA1 antibody to visualize
SGs (TIA-1, red) and anti-PABP1 antibody to determine its
subcellular distribution (PABP, blue). Expression of the myc-
tagged constructs was visualized using anti-myc antibody. Scale
bars=20 mm.
(TIF)
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